New Blood Test Predicts COVID-9 Recovery

Developing sudden failure of organs that leads to various complications like respiratory or kidney inefficiency or requiring other intensive care remains one of the challenging aspects of COVID-19 that may cause death even in young patients.

With an aim to explore which hospitalized patients can get into such complications, involving nearly 100 patients newly admitted to the hospital with COVID-19, a simple and rapid blood test has been formulated by scientists at Washington University School of Medicine in St. Louis.

COVID-19 : How the Risk Factors Contribute to Treatment Options
COVID-19 has greater potency to affect hospitalized patients who are obese, have complications from diabetes or hypertension, especially in men.

‘New rapid blood test that measures levels of mitochondrial DNA, a unique type of DNA molecule that normally resides inside the energy factories of cells – mitochondria, helps predict patients who are at risk of developing organ failures from COVID-19. This test may aid in triaging patients according to their severity of the disease.’

Within a day of a hospital admission, this blood test can predict the risk of patients with COVID-19 who are highly prone to develop severe complications or death, published in the journal JCI Insight.

The blood test measures levels of mitochondrial DNA, a unique type of DNA molecule that normally resides inside the energy factories of cells – mitochondria. Spilling out of cells from the mitochondrial DNA into the bloodstream indicates the presence of violent cell death in the body.

The Rapid Blood Test for COVID-19

Respiratory Rate and Breath-Count Calculator
Respiratory Rate and Breath-Count Calculator calculates the respiratory rate and number of breaths. More on how breathing exercises and meditation practices are necessary for good health.

It was found that the mitochondrial DNA levels were much higher – almost tenfold in patients who eventually were admitted to the ICU, intubated or died, independent of a patient's age, sex and underlying health conditions.

"There's so much we still don't understand about this disease. In particular, we need to understand why some patients, irrespective of their ages or underlying health in some cases, go into this hyper inflammatory death spiral. Our study suggests that tissue damage may be one cause of this spiral, since the mitochondrial DNA that is released is itself an inflammatory molecule", says co-senior author Andrew E. Gelman, PhD, the Jacqueline G. and William E. Maritz Endowed Chair in Immunology and Oncology in the Department of Surgery.

Wearing Mask may Itself Lead to Contract COVID-19 Infection
Wearing a mask has become a mandatory action to slow the spread of surging COVID-19. But if it’s not accompanied by proper public education, the practice could lead to more infections.

This test might help predict disease severity as well as serve as a tool to better design clinical trials, identifying patients who might, for example, benefit from specific investigational treatments. The test offers inflammatory markers specific to cell death as compared to other trials that measure general systemic inflammation.

However the team affirmed that larger trials are needed to yet verify the present results. This would then aid in triaging and managing the patients who are at requirement of intensive care unit in the first 24 hours of admission.

Breathing Slowly may Increase the Risk to COVID-19
Slower and deeper breathing increases the risk of contracting the COVID-19 infection as it allows the aerosol particles to deposit deep in the lung.

"Viruses can cause a type of tissue damage called necrosis that is a violent, inflammatory response to the infection. The cell breaks open, releasing the contents, including mitochondrial DNA, which itself drives inflammation. In COVID-19 patients, there has been anecdotal evidence of this type of cell and tissue damage in the lung, heart and kidney. We think it's possible that measures of mitochondrial DNA in the blood may be an early sign of this type of cell death in vital organs", says Gelman.

The blood test is quick and it uses the same machinery that processes the standard PCR test for COVID-19. There are no intermediate steps to extract the DNA from the blood and thus it returns the results in less than an hour.

Upon verification of results in a larger multi-center trial, the diagnostic method could anticipate approval from the Food and Drug Administration (FDA) for its usage in hospitals.

Source-Medindia